Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBT: 2016-2021

Historic EBT for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' EBT fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
  • As of Q4 2021, ENDRA Life Sciences' EBT stood at -$3.1 million, which was down 16.79% from -$2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year EBT high stood at -$741,623 for Q1 2017, and its period low was -$4.8 million during Q4 2019.
  • Its 3-year average for EBT is -$3.0 million, with a median of -$3.0 million in 2020.
  • As far as peak fluctuations go, ENDRA Life Sciences' EBT plummeted by 280.96% in 2018, and later surged by 53.20% in 2020.
  • ENDRA Life Sciences' EBT (Quarterly) stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then crashed by 103.30% to -$4.8 million in 2019, then soared by 53.20% to -$2.3 million in 2020, then crashed by 37.94% to -$3.1 million in 2021.
  • Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.